Researchers conducted a cohort study to try to characterize long-term treatment-related adverse effects and complications in ...
Physicians say the trends with insurers’ prior authorization requirements are escalating demands for time from doctors and ...
The majority of patients may safely take glucagon-like peptide 1 receptor agonists (GLP-1 RAs) before elective surgery and ...
In the United States, out-of-pocket (OOP) costs of brand-name medications for neurological disorders increased significantly ...
About 1 in 6 women experience symptoms of postpartum depression (PPD) 2 months after cesarean delivery, with certain ...
Levonorgestrel intrauterine devices (IUDs) are associated with significantly more reports of acne, alopecia, and hirsutism ...
On September 27, 2024, UMC Health System in Lubbock, Texas, experienced an IT outage due to a cybersecurity incident that ...
The new administration of President-Elect Donald Trump could mean the end of extra premium subsidies under the Affordable ...
Both infliximab and adalimumab are safe and effective in achieving remission in patients with severe mucocutaneous Behçet ...
Genetic testing of patients with inherited retinal diseases may be less likely to turn up a conclusive diagnosis for certain ...
Practice-changing studies in dry age-related macular degeneration (AMD) and promising new directions in wet AMD, presented at ...
A phospholipid nanoemulsion–based ocular lubricant applied twice daily is well tolerated, improves the stability of tear film, and alleviates symptoms in patients with dry eye disease. Researchers ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback